Related references
Note: Only part of the references are listed.Celastrol Attenuates Angiotensin II-Induced Cardiac Remodeling by Targeting STAT3
Shiju Ye et al.
CIRCULATION RESEARCH (2020)
Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018
Paul Muntner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Biglycan is a new high-affinity ligand for CD14 in macrophages
Heiko Roedig et al.
MATRIX BIOLOGY (2019)
Loss of SRSF3 in Cardiomyocytes Leads to Decapping of Contraction-Related mRNAs and Severe Systolic Dysfunction
Paula Ortiz-Sanchez et al.
CIRCULATION RESEARCH (2019)
New Approaches to Target Inflammation in Heart Failure: Harnessing Insights from Studies of Immune Cell Diversity
Aaron J. Rhee et al.
Annual Review of Physiology (2019)
Wnt5a is a TLR2/4-ligand that induces tolerance in human myeloid cells
Meliha Mehmeti et al.
COMMUNICATIONS BIOLOGY (2019)
CXCL1-CXCR2 axismediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation ofmonocyte infiltration
Lei Wang et al.
EUROPEAN HEART JOURNAL (2018)
Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis
Anne-Catherine Raby et al.
KIDNEY INTERNATIONAL (2018)
The Role of Toll-Like Receptor Signaling in the Progression of Heart Failure
Lili Yu et al.
MEDIATORS OF INFLAMMATION (2018)
ANGIOTENSIN II SIGNAL TRANSDUCTION: AN UPDATE ON MECHANISMS OF PHYSIOLOGY AND PATHOPHYSIOLOGY
Steven J. Forrester et al.
PHYSIOLOGICAL REVIEWS (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway
Jibo Han et al.
BASIC RESEARCH IN CARDIOLOGY (2017)
Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics
Wei Gao et al.
FRONTIERS IN PHYSIOLOGY (2017)
Pathogen-Induced TLR4-TRIF Innate Immune Signaling in Hematopoietic Stem Cells Promotes Proliferation but Reduces Competitive Fitness
Hitoshi Takizawa et al.
CELL STEM CELL (2017)
Trimetazidine prevents macrophage-mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin 1
Jing Chen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure
Vaibhav B. Patel et al.
CIRCULATION RESEARCH (2016)
Innate Immunity and the Failing Heart The Cytokine Hypothesis Revisited
Douglas L. Mann
CIRCULATION RESEARCH (2015)
Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation
Lei Wang et al.
CARDIOVASCULAR RESEARCH (2014)
Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries
Clara K. Chow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Toll-Like Receptor-2 Mediates Adaptive Cardiac Hypertrophy in Response to Pressure Overload Through Interleukin-1β Upregulation via Nuclear Factor κB Activation
Yasutomi Higashikuni et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Angiotensin II induces inflammation leading to cardiac remodeling
Lixin Jia et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2012)
Toll-Like Receptor (TLR) 2 and TLR4 Differentially Regulate Doxorubicin Induced Cardiomyopathy in Mice
Yonggang Ma et al.
PLOS ONE (2012)
The role of TLR2 in infect on and immunity
Laura Oliveira-Nascimento et al.
FRONTIERS IN IMMUNOLOGY (2012)
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
J. C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
TIMP2 Deficiency Accelerates Adverse Post-Myocardial Infarction Remodeling Because of Enhanced MT1-MMP Activity Despite Lack of MMP2 Activation
Vijay Kandalam et al.
CIRCULATION RESEARCH (2010)
Endogenous toll-like receptor ligands and their biological significance
Li Yu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Targeting Toll-like receptors: emerging therapeutics?
Elizabeth J. Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Tumor Necrosis Factor-alpha-Converting Enzyme Is a Key Regulator of Agonist-Induced Cardiac Hypertrophy and Fibrosis
Xiang Wang et al.
HYPERTENSION (2009)
Bridging innate immunity and myocardial ischemia/reperfusion injury: The search for therapeutic targets
Fatih Arslan et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE
Vilma Urbonaviciute et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Role of pattern-recognition receptors in cardiovascular health and disease
J. A. Mitchell et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction
T Shishido et al.
CIRCULATION (2003)
Role of toll-like receptors in pathogen recognition
S Janssens et al.
CLINICAL MICROBIOLOGY REVIEWS (2003)
Role of TLR-8 in the activation of nuclear factor κB by oxidative stress in cardiac myocytes
S Frantz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
